BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 18594005)

  • 1. Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.
    Alexander AA; Maniar A; Cummings JS; Hebbeler AM; Schulze DH; Gastman BR; Pauza CD; Strome SE; Chapoval AI
    Clin Cancer Res; 2008 Jul; 14(13):4232-40. PubMed ID: 18594005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity.
    Poonia B; Pauza CD
    Cytotherapy; 2012 Feb; 14(2):173-81. PubMed ID: 22029653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and synthesis of fibroblast growth factor-9 in human gammadelta T-lymphocytes. Response to isopentenyl pyrophosphate and TGF-beta1/IL-15.
    Workalemahu G; Foerster M; Kroegel C
    J Leukoc Biol; 2004 Apr; 75(4):657-63. PubMed ID: 14704367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses.
    Qin G; Mao H; Zheng J; Sia SF; Liu Y; Chan PL; Lam KT; Peiris JS; Lau YL; Tu W
    J Infect Dis; 2009 Sep; 200(6):858-65. PubMed ID: 19656068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood.
    Kang N; Zhou J; Zhang T; Wang L; Lu F; Cui Y; Cui L; He W
    Cancer Biol Ther; 2009 Aug; 8(16):1540-9. PubMed ID: 19471115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 activates Vγ9Vδ2
    Murday AS; Chaudhry S; Pauza CD
    Immunology; 2017 Aug; 151(4):385-394. PubMed ID: 28342224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2.
    Li W; Kubo S; Okuda A; Yamamoto H; Ueda H; Tanaka T; Nakamura H; Yamanishi H; Terada N; Okamura H
    J Immunother; 2010 Apr; 33(3):287-96. PubMed ID: 20445349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation.
    Minculescu L; Sengelov H; Marquart HV; Ryder LP; Fischer-Nielsen A; Haastrup E
    Front Immunol; 2021; 12():625165. PubMed ID: 33777007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.
    Maniar A; Zhang X; Lin W; Gastman BR; Pauza CD; Strome SE; Chapoval AI
    Blood; 2010 Sep; 116(10):1726-33. PubMed ID: 20519625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.
    Tawfik D; Groth C; Gundlach JP; Peipp M; Kabelitz D; Becker T; Oberg HH; Trauzold A; Wesch D
    Front Immunol; 2019; 10():2044. PubMed ID: 31555275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.
    Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J
    BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFNalpha2b stimulated release of IFNgamma differentially regulates T cell and NK cell mediated tumor cell cytotoxicity.
    Bose A; Baral R
    Immunol Lett; 2007 Jan; 108(1):68-77. PubMed ID: 17112599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.
    Knight A; Mackinnon S; Lowdell MW
    Cytotherapy; 2012 Oct; 14(9):1110-8. PubMed ID: 22800570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
    Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
    J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amplification efficency and optimization of culture conditions of γδ T cells in peripheral blood by different phosphate compounds].
    Xi Y; Miao T; Wan L; Wang Y; Feng T; Gong T; Li M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):868-71. PubMed ID: 25108442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells.
    Schilbach KE; Geiselhart A; Wessels JT; Niethammer D; Handgretinger R
    J Immunother; 2000; 23(5):536-48. PubMed ID: 11001547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive activity of Vδ2
    Schilbach K; Krickeberg N; Kaißer C; Mingram S; Kind J; Siegers GM; Hashimoto H
    Cancer Immunol Immunother; 2020 Apr; 69(4):593-610. PubMed ID: 31982940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.